Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD 0200390 dose-ranging trial in nonrestorative sleep
NCT00655369Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of Atagabalin in Non-restorative sleep (NRS) (6 arms), sponsored by Pfizer. Primary endpoint: Restorative Sleep Questionnaire - Weekly. Started Apr 2008; status: completed.
02
Drugs
Atagabalin
03
Conditions
Non-restorative sleep (NRS)
Beyond the preview
Go deeper on NCT00655369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655369.